Derinat, 0.25% 10 ml

The drug activates cellular and humoral immunity. Optimizes specific reactions against fungal, viral and bacterial infections. The drug stimulates reparative and regenerative processes, normalizes tissues and organs in dystrophies of vascular origin.

Derinat promotes healing of trophic ulcers of various etiologies. Derinat promotes rapid healing of deep burns, significantly accelerating the dynamics of epithelization. When restoring ulcers on the mucosa under the action of Derinat there is a scarless recovery. The drug has no teratogenic and carcinogenic actions.

Pharmacokinetics:

Derinat when applied topically is quickly absorbed and distributed in the organs and tissues with the participation of the endolymphatic transport route. During the phase of intensive entry of the drug into the blood, redistribution between the plasma and the blood forming elements occurs in parallel with metabolism and excretion. Derinat is metabolized in the body.

It is excreted from the body (as metabolites) partially in the feces and, to a greater extent, in the urine in a biexponential relationship.

Indications

Monotherapy:

acute respiratory diseases (ARI);
prevention and treatment of acute respiratory viral infections (ARVI);
ophthalmology: inflammatory and dystrophic processes;
inflammatory diseases of the mucous membranes of the oral cavity;

Complex therapy:

chronic inflammatory diseases, fungal, bacterial and other infections of the mucous membranes in gynecology;
acute and chronic diseases of the upper respiratory tract (rhinitis, sinusitis, sinusitis, sinusitis);
obliterating diseases of the lower extremities;
trophic ulcers, long-term non-healing and infected wounds (including diabetes mellitus);
gangrene;
burns, frostbite;
haemorrhoids;
post-radiation necrosis of the skin and mucous membranes.

Pharmacological effect

The drug activates cellular and humoral immunity. Optimizes specific responses against fungal, viral and bacterial infections. The drug stimulates reparative and regenerative processes, normalizes the condition of tissues and organs in dystrophies of vascular origin.

Derinat promotes the healing of trophic ulcers of various etiologies. Derinat promotes rapid healing of deep burns, significantly accelerating the dynamics of epithelization. When ulcerative formations on the mucous membrane are restored under the influence of Derinat, scarless restoration occurs. The drug does not have teratogenic or carcinogenic effects.

Pharmacokinetics:

Derinat, when applied topically, is quickly absorbed and distributed in organs and tissues via the endolymphatic transport route. During the phase of intensive entry of the drug into the blood, redistribution occurs between plasma and blood cells, in parallel with metabolism and excretion. Derinat is metabolized in the body.

It is excreted from the body (in the form of metabolites) partially with feces, and, to a greater extent, with urine according to a biexponential dependence.

Active ingredient

Sodium deoxyribonucleate

Composition

1 ml of solution contains sodium deoxyribonucleate – 2.5 mg,

sodium chloride – 1.0 mg

Contraindications

hypersensitivity to the components of the drug.

Side Effects

No side effects were identified with external or local use of the drug.

Storage conditions

Store in a place protected from light, at a temperature not exceeding 25C

Manufacturer

FZ Immunnolex, Russia